A5083556099- Diversity and Career in Medicine
- Empathy and Medical Education
- Healthcare professionals’ stress and burnout
- Maternal Mental Health During Pregnancy and Postpartum
- Healthcare cost, quality, practices
- Ovarian cancer diagnosis and treatment
- Medical Education and Admissions
- Innovations in Medical Education
- Social Media in Health Education
- CRISPR and Genetic Engineering
- Forensic Toxicology and Drug Analysis
- CAR-T cell therapy research
- Endometriosis Research and Treatment
- Biomedical and Engineering Education
- Transgenic Plants and Applications
- Poisoning and overdose treatments
- Pregnancy and Medication Impact
- Cutaneous Melanoma Detection and Management
- Primary Care and Health Outcomes
- Healthcare Decision-Making and Restraints
- Melanoma and MAPK Pathways
- Galectins and Cancer Biology
- Botulinum Toxin and Related Neurological Disorders
- Testicular diseases and treatments
- Healthcare Systems and Challenges
Edward Hines, Jr. VA Hospital
2009-2024
University of California, San Diego
2023-2024
Boston University
2024
Oregon Health & Science University
2019-2024
Portland VA Medical Center
2024
Westmead Hospital
2023
Loyola University Medical Center
2015-2019
Stanford University
2019
Loyola University Chicago
2017-2019
Cancer Australia
2016
Monee Rassolian, MD; Lars E. Peterson, MD, PhD; Bo Fang, H. Clifton Knight Jr, Michael R. Peabody, Elizabeth G. Baxley, Arch Mainous III, PhD
It is unknown whether melanoma patients achieving complete response (CR) with targeted therapy can safely discontinue treatment.All treated BRAF/MEK inhibitors CR and ceasing treatment before progression were identified. Clinical data at initiation, cessation examined.A total of 12 eligible identified, median follow-up 16 months, whom 6 (50%) recurred a 6.6 months after cessation. One patient lost to until presentation symptomatic recurrence was the only relapser die. At relapse, remaining...
Platinum-based chemotherapy is the backbone of medical management ovarian cancer. The dose, route and timing treatment are ongoing areas debate. Intraperitoneal (IP) an alternative delivery method to conventional intravenous (IV) for patients with epithelial cancer, efficacy supported by Level 1 evidence.
Drs. John and Ford reported in biomedicines that a variant transcript encoding receptor tyrosine kinase-like orphan 1 (ROR1), namely ENST00000545203 or 3 (ROR1V3), was predominant ROR1 of neoplastic normal cells the Bioinformatic database, including GTEx 33 datasets from TCGA. Unlike full-length transcript, deduced ROR1V3 encoded cytoplasmic protein lacking an apparent signal peptide necessary for transport to cell surface, which they presumed made it unlikely function as surface...
Back to table of contents Previous article Next ProfessionalFull AccessReinventing Networking During Era Social DistancingPallavi Joshi, D.O., M.A., Christina Girgis, M.D., Daniel Cho, M.P.H., Jose Vito, M.D.Pallavi M.D.Published Online:15 Jun 2020https://doi.org/10.1176/appi.pn.2020.6a33AbstractAs we become accustomed living in a virtual world, can make the most it by keeping mind certain points.Professional networking medicine is important for refining career goals, building strategic...